GC CELL CORPORATION

Organization

SEOUL, KR

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeri...
- Patent number 12,116,417
- Issue date Oct 15, 2024
- GC Cell Corporation
- Jong Seo Lee
- G01 - MEASURING TESTING
Information Patent Grant
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeri...
- Patent number 11,970,547
- Issue date Apr 30, 2024
- GC Cell Corporation
- Jong Seo Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for culturing natural killer cells using T cells
- Patent number 11,766,456
- Issue date Sep 26, 2023
- GC Cell Corporation
- Bo Kyung Min
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeri...
- Patent number 11,649,294
- Issue date May 16, 2023
- GC Cell Corporation
- Jong Seo Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERI...
- Publication number 20240409665
- Publication date Dec 12, 2024
- GC Cell Corporation
- Jong Seo LEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND AN EGFR TARGETED ANTIBODY
- Publication number 20240366664
- Publication date Nov 7, 2024
- Artiva Biotherapeutics, Inc.
- Yusun KIM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIG...
- Publication number 20240366663
- Publication date Nov 7, 2024
- Artiva Biotherapeutics, Inc.
- Yusun KIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERI...
- Publication number 20240270872
- Publication date Aug 15, 2024
- GC Cell Corporation
- Jong Seo Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A HER2 TARGETED ANTIBODY
- Publication number 20240197778
- Publication date Jun 20, 2024
- Artiva Biotherapeutics, Inc.
- Yusun KIM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY
- Publication number 20240180962
- Publication date Jun 6, 2024
- Artiva Biotherapeutics, Inc.
- Sungyoo CHO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY
- Publication number 20240115704
- Publication date Apr 11, 2024
- Artiva Biotherapeutics, Inc.
- Peter FLYNN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXPANDED AND STIMULATED NATURAL KILLER CELLS
- Publication number 20240060046
- Publication date Feb 22, 2024
- Artiva Biotherapeutics, Inc.
- Seungryel Han
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method for Culturing Natural Killer Cells Using T Cells
- Publication number 20240050478
- Publication date Feb 15, 2024
- GC Cell Corporation
- Bo Kyung Min
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY
- Publication number 20240000840
- Publication date Jan 4, 2024
- Artiva Biotherapeutics, Inc.
- Yu Kyeong Hwang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERI...
- Publication number 20230303716
- Publication date Sep 28, 2023
- GC Cell Corporation
- Jong Seo Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL TRANSPLANTATION CELLS HAVING REDUCED IMMUNOGENICITY
- Publication number 20230242894
- Publication date Aug 3, 2023
- GC CELL CORPORATION
- Hyun Ah KIM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Medium Composition for Cryopreservation of Cell and Use Thereof
- Publication number 20230108578
- Publication date Apr 6, 2023
- GC Cell Corporation
- Yu Kyeong Hwang
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Chimeric Antigen Receptor and Natural Killer Cells Expressing Same
- Publication number 20230025506
- Publication date Jan 26, 2023
- GC Cell Corporation
- Yu Kyeong Hwang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

GC CELL CORPORATION

Organization

Patents Grantslast 30 patents

Anti-HER2 antibody or antigen-binding fragment thereof, and chimeri...

Anti-HER2 antibody or antigen-binding fragment thereof, and chimeri...

Method for culturing natural killer cells using T cells

Anti-HER2 antibody or antigen-binding fragment thereof, and chimeri...

Patents Applicationslast 30 patents

ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERI...

TREATMENT OF CANCER WITH NK CELLS AND AN EGFR TARGETED ANTIBODY

CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIG...

ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERI...

TREATMENT OF CANCER WITH NK CELLS AND A HER2 TARGETED ANTIBODY

TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY

TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY

EXPANDED AND STIMULATED NATURAL KILLER CELLS

Method for Culturing Natural Killer Cells Using T Cells

TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY

ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERI...

NOVEL TRANSPLANTATION CELLS HAVING REDUCED IMMUNOGENICITY

Medium Composition for Cryopreservation of Cell and Use Thereof

Chimeric Antigen Receptor and Natural Killer Cells Expressing Same

Trademarklast 30 trademarks